Feng Chi Biotech Corp Ordinary Shares 6744
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 20.50
- Day Range
- TWD 20.20–20.50
- 52-Week Range
- TWD 19.10–25.00
- Bid/Ask
- TWD 19.80 / TWD 20.40
- Market Cap
- TWD 311.08 Mil
- Volume/Avg
- 4,351 / 10,997
Key Statistics
- Price/Earnings (Normalized)
- 16.53
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 5.12%
- Dividend Yield (Forward)
- 5.12%
- Total Yield
- 5.12%
Company Profile
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 32
- Website
- http://www.fcbiotech.com.tw
Valuation
|
Metric
|
6744
|
|---|---|
Price/Earnings (Normalized) | 16.53 |
Price/Book Value | 1.36 |
Price/Sales | 1.84 |
Price/Cash Flow | 11.91 |
Price/Earnings
6744
Financial Strength
|
Metric
|
6744
|
|---|---|
Quick Ratio | 3.83 |
Current Ratio | 4.18 |
Interest Coverage | 72.41 |
Quick Ratio
6744
Profitability
|
Metric
|
6744
|
|---|---|
Return on Assets (Normalized) | 6.34% |
Return on Equity (Normalized) | 8.29% |
Return on Invested Capital (Normalized) | 6.96% |
Return on Assets
6744
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Bscfkmjc | Gtxd | $524.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Ytbvygbh | Phjmvq | $120.0 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Twcdxyr | Llymjw | $115.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Kprfkcz | Ltpcyn | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Sncdhmpbc | Vkbc | $32.4 Bil | |||
| BioNTech SE ADR
BNTX
| Khgglrpgh | Smttc | $28.2 Bil | |||
| Moderna Inc
MRNA
| Rychltyw | Lkql | $25.7 Bil | |||
| United Therapeutics Corp
UTHR
| Smbqcvhj | Wtccn | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Bcqdqnwc | Swmjn | $13.4 Bil | |||
| Incyte Corp
INCY
| Tnkrrqr | Qmglnk | $12.7 Bil |
United States